Synovial tissue macrophage populations and articular damage in rheumatoid arthritis.
暂无分享,去创建一个
[1] J. Woody,et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.
[2] F. Wolfe,et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. , 1994, Arthritis and rheumatism.
[3] G. Firestein,et al. Pannus and pannocytes , 1994 .
[4] G. Panayi,et al. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. , 1994, Annals of the rheumatic diseases.
[5] G. Firestein,et al. Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression. , 1994, Arthritis and rheumatism.
[6] B. Bresnihan,et al. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.
[7] F. Breedveld,et al. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. , 1993, Arthritis and rheumatism.
[8] G. Panayi. The pathogenesis of rheumatoid arthritis: from molecules to the whole patient. , 1993, British journal of rheumatology.
[9] Bucy Rp,et al. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. , 1993, Arthritis and rheumatism.
[10] F. Emmrich,et al. Reduction of monocyte‐macrophage activation markers upon anti‐CD4 treatment. Decreased levels of IL‐1, IL‐6, neopterin and soluble CD14 in patients with rheumatoid arthritis , 1993, Clinical and experimental immunology.
[11] K. Elkon,et al. The SCID mouse as a vehicle to study autoimmunity. , 1993, British journal of rheumatology.
[12] A. Pitsillides,et al. Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). , 1992, Arthritis and rheumatism.
[13] M. Feldmann,et al. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. , 1992, British journal of rheumatology.
[14] J. Isaacs,et al. Humanised monoclonal antibody therapy for rheumatoid arthritis , 1992, The Lancet.
[15] F. Thien,et al. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis. , 1992, The Journal of rheumatology.
[16] G. Firestein,et al. Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. , 1992, The American journal of pathology.
[17] J. Symons,et al. In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. , 1992, Clinical immunology and immunopathology.
[18] G. Panayi. The immunopathogenesis of rheumatoid arthritis. , 1979, Clinical and experimental rheumatology.
[19] H. Stein,et al. Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. , 1991, Journal of clinical pathology.
[20] B. Bresnihan,et al. Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.
[21] M. Bayliss,et al. The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. , 2010, Arthritis and rheumatism.
[22] M. Tocci,et al. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. , 1990, Journal of immunology.
[23] J. McGee,et al. Labelling of cells of the mononuclear phagocyte system in routinely processed archival biopsy specimens with monoclonal antibody EBM/11. , 1990, Journal of clinical pathology.
[24] J. Sany,et al. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. , 1990, The Journal of rheumatology.
[25] L. Wilkinson,et al. Immunohistological reassessment of accessory cell populations in normal and diseased human synovium. , 1990, British journal of rheumatology.
[26] G. Firestein,et al. How important are T cells in chronic rheumatoid synovitis? , 1990, Arthritis and rheumatism.
[27] F. Epstein,et al. Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.
[28] P. Lydyard,et al. The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. , 1990, Scandinavian journal of rheumatology.
[29] B. Bresnihan,et al. Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads. , 1989, Arthritis and rheumatism.
[30] B. Bresnihan,et al. Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. , 1989, Arthritis and rheumatism.
[31] B. Bresnihan,et al. The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis. , 1989, The Journal of rheumatology.
[32] O. Söder,et al. Stimulation of chondrocyte DNA synthesis by interleukin-1. , 1988, British journal of rheumatology.
[33] Dawes Pt. Radiological assessment of outcome in rheumatoid arthritis. , 1988 .
[34] G. Firestein,et al. Down regulation of human monocyte differentiation antigens by interferon gamma. , 1987, Cellular immunology.
[35] M. T. Walters,et al. An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy. , 1987, Annals of the rheumatic diseases.
[36] L. Poulter,et al. Macrophage-like cells of the pannus area in rheumatoid arthritic joints. , 1987, Scandinavian journal of rheumatology.
[37] R. Hoppe,et al. Long-term followup of rheumatoid arthritis patients treated with total lymphoid irradiation. , 1987, Arthritis and rheumatism.
[38] G. Janossy,et al. Discrimination of Human Macrophages and Dendritic Cells by Means of Monoclonal Antibodies , 1986, Scandinavian journal of immunology.
[39] D. Scott,et al. Long term progression of joint damage in rheumatoid arthritis. , 1986, Annals of the rheumatic diseases.
[40] N. Hogg,et al. Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. , 1985, Immunology.
[41] P. Bacon,et al. Progression of radiological changes in rheumatoid arthritis. , 1984, Annals of the rheumatic diseases.
[42] R. Winchester,et al. Identification of Three Major Synovial Lining Cell Populations by Monoclonal Antibodies Directed to Ia Antigens and Antigens Associated with Monocytes/Macrophages and Fibroblasts , 1983, Scandinavian journal of immunology.
[43] G. Janossy,et al. Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. , 1982, Clinical and experimental immunology.
[44] L. Klareskog,et al. Appearance of Anti‐HLA‐DR‐Reactive Cells in Normal and Rheumatoid Synovial Tissue , 1981, Scandinavian journal of immunology.
[45] R. Mallya,et al. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. , 1981, Rheumatology and rehabilitation.
[46] H. Paulus,et al. Lymphocyte Involvement in Rheumatoid Arthritis , 1977 .
[47] A. Larsen,et al. Radiographic Evaluation of Rheumatoid Arthritis and Related Conditions by Standard Reference Films , 1977, Acta radiologica: diagnosis.
[48] H. Ishikawa,et al. Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. , 1976, Arthritis and rheumatism.
[49] M. Ziff,et al. Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. , 1975, Arthritis and rheumatism.
[50] K. Muirden,et al. Do Lymphocytes Protect the Rheumatoid Joint? , 1971, British medical journal.
[51] W. Buchanan,et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. , 1968, The Quarterly journal of medicine.